Another interesting example of RNAi-based therapy is that applicated to spinal muscular atrophy (SMA); particularly, the approach enables modification of defective transcripts from the survival motor neuron (SMN2) gene to induce gene transcription and translation into the SMN protein and restore its function. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.